| Impact of COVID-19 on Pharmacy Residency Programs: Part 1 |
| Managing Drug Excipient Toxicities in the wake of COVID-19 |
| ASHP Business Recovery Toolkit |
| Clinician Perspectives on the Impact of Pharmacogenetics on Treating Patients With Coronavirus
|
| Technology Platforms Used to Conduct Telehealth Visits |
| Clinician Perspectives on the Management of Critically Ill COVID-19 patients at Harborview Medical Center |
| Clinician Perspectives on Antimicrobial Stewardship and Infectious Diseases Management in COVID-19 |
| Home Infusion: Responding to COVID-19 Practice Model Adjustments and Outcomes |
| Supporting the Pharmacy Workforce during COVID-19: An Introduction to Critical Incident Stress Management |
| COVID-19 Pharmacy Response Across A Multi-Region Health-System |
| Caring for Transplant Patients during COVID-19 |
| What’s Next for the Adaptive COVID Treatment Trial? |
| Caring for the Pharmacy Workforce during COVID-19 |
| Navigating the world of residences in a COVID-19 world |
| ASHP Surge Toolkit |
| The Pharmacist’s Role in Resource Utilization Oversight |
| ASHP Launches COVID Care Certified Product |
| Transitions of Care and Outpatient management and the Harborview Seattle Experience |
| Seattle Surge Lessons and Next Steps |
| Patient Management Lessons Learned from NYU Langone: Focus on Evidence-Based Medicine |
| Student Perspectives: COVID-19 Impact on Student Societies Part II |
| Clinician Perspectives on Behavioral Health Management |
| Student Perspectives: COVID-19 Impact on Student Societies |
| Remdesivir: Early Use in Search for its Niche |
| Clinician Perspectives on Cytokine Storm |
| Clinician Perspectives on Anticoagulation |
| Parenteral Anticoagulation in Patients that are Obese |
| Preparing Childrens' Hospitals for the Adult COVID-19 Surge |
| Expansion of Telehealth Pharmacy Services in the Face of the COVID-19 Pandemic: Perspectives of a Preceptor and PGY2 Ambulatory Care Resident |
| Managing Workforce Fatigue and Organizational Best Practices During the COVID-19 Pandemic |
| Clinician Perspectives on Geriatric Practice Considerations |
| Distance Learning: COVID-19 Experiential Rotations and the Virtual Classroom |
| Expansion of Telehealth Pharmacy Services in the Face of the COVID-19 Pandemic |
| Keeping Up to Date Revisiting ASHPs Assessment of Evidence for COVID-19 Related Treatments |
| Clinician Perspectives on the Society of Critical Care Medicine's Guidelines on Critically Ill Patients |
| Pharmacy Response in New York City Region: Lessons Learned From NYC Region Pharmacy Leadership |
| A Tale of 2 ICUs |
| Clinician Perspectives on Workforce and Personal Well-Being with Bethany Withycombe and Maggie Kronz |
| Clinician Perspectives on Distance Learning and Virtual Rotations |
| Working with the Federal Agencies |
| Pharmacy Response in New Jersey Community Hospital Hot Spot: Holy Name Medical Center |
| Clinician Perspectives on Workforce Well-Being with Laura Truhlar |
| Clinical Perspectives: Can a Vitamin or Antioxidant a Day Keep the Sepsis Away? |
| ASHP Launches New COVID-19 Microsite |
| From the Frontline of COVID-19: Clinician Perspectives on Workforce Well-Being with Anne Nguyen |
| COVID-19: Clinician Perspectives on Crisis Management and ICU Creations at your Institution |
| COVID-19: Field Hospital Deployment: One Perspective from an Army Pharmacist |
| From the Frontline of COVID-19: Managing Remote Rotations |
| COVID-19 and Alcohol Withdrawal Syndrome |
| COVID-19 and Managing the Surge: Lessons Learned
|
| COVID-19: Managing Airways and Acute Respiratory Distress
|
| From the Frontline of COVID-19: Keeping up with the Literature |
| COVID-19: Workforce Well-Being, Maintaining Health, (Trying to) Stay Resilient with Lisa Wilhelm |
| From the Frontline of COVID-19: Clinician Perspectives on Hydroxychloroquine and Chloroquine Toxicity |
| COVID-19: Resources to Combat Staffing Shortage |
| COVID-19: Scarce Resources and Ethical Decision Making |
| COVID-19: Updates on Supply Chain Management and ASHP Legislative Efforts |
| Ethical Considerations in Prioritizing Care: Oncology Perspectives |
| COVID-19: Pharmacy Practice Leaders – Lesson Learned Series (Part 3) |
| COVID-19 Managing Drug Shortages |
| COVID-19: Pharmacy Practice Leaders – Lesson Learned Series (Part 2) |
| COVID-19: Ethical Considerations |
| COVID-19: Pharmacy Practice Leaders – Lesson Learned Series (Part 1) |
| COVID-19 Evaluating the Literature |
| COVID-19 and Pharmacy Preparedness |
